Evidence map›Paper›PMID 32024912›Full record

ArticleScientific reports2020

Publisher Correction: Preconditioning the Initial State of Feeder-free Human Pluripotent Stem Cells Promotes Self-formation of Three-dimensional Retinal Tissue.

Atsushi Kuwahara, Suguru Yamasaki, Michiko Mandai, Kenji Watari, Keizo Matsushita, Masayo Fujiwara, Yoriko Hori, Yasushi Hiramine, Daiki Nukaya, Miki Iwata and 4 more

Open access · goldAbstract readPublished Erratum
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Atsushi Kuwahara *Regenerative & Cellular Medicine Kobe Center, Sumitomo Dainippon Pharma Co., Ltd., Chuo, Kobe, 650-0047, Japan. atsushi-kuwahara@ds-pharma.co.jp.ORCID http://orcid.org/0000-0003-2418-7853
Suguru Yamasaki *Regenerative & Cellular Medicine Kobe Center, Sumitomo Dainippon Pharma Co., Ltd., Chuo, Kobe, 650-0047, Japan.ORCID http://orcid.org/0000-0003-3370-5851
Michiko MandaiLaboratory for Retinal Regeneration, RIKEN Center for Developmental Biology, Chuo, Kobe, 650-0047, Japan.
Kenji WatariRegenerative & Cellular Medicine Kobe Center, Sumitomo Dainippon Pharma Co., Ltd., Chuo, Kobe, 650-0047, Japan.
Keizo MatsushitaRegenerative & Cellular Medicine Office, Sumitomo Dainippon Pharma Co., Ltd., Chuo, Kobe, 650-0047, Japan.
Masayo FujiwaraRegenerative & Cellular Medicine Kobe Center, Sumitomo Dainippon Pharma Co., Ltd., Chuo, Kobe, 650-0047, Japan.
Yoriko HoriRegenerative & Cellular Medicine Kobe Center, Sumitomo Dainippon Pharma Co., Ltd., Chuo, Kobe, 650-0047, Japan.
Yasushi HiramineRegenerative & Cellular Medicine Office, Sumitomo Dainippon Pharma Co., Ltd., Chuo, Kobe, 650-0047, Japan.
Daiki NukayaRegenerative & Cellular Medicine Kobe Center, Sumitomo Dainippon Pharma Co., Ltd., Chuo, Kobe, 650-0047, Japan.
Miki IwataRegenerative & Cellular Medicine Kobe Center, Sumitomo Dainippon Pharma Co., Ltd., Chuo, Kobe, 650-0047, Japan.
Akiyoshi KishinoRegenerative & Cellular Medicine Kobe Center, Sumitomo Dainippon Pharma Co., Ltd., Chuo, Kobe, 650-0047, Japan.
Masayo TakahashiLaboratory for Retinal Regeneration, RIKEN Center for Developmental Biology, Chuo, Kobe, 650-0047, Japan.
Yoshiki SasaiLaboratory for Neurogenesis and Organogenesis, RIKEN Center for Developmental Biology, Chuo, Kobe, 650-0047, Japan.
Toru KimuraRegenerative & Cellular Medicine Kobe Center, Sumitomo Dainippon Pharma Co., Ltd., Chuo, Kobe, 650-0047, Japan.
Sumitomo Dainippon Pharma (Japan) · JPRIKEN Center for Biosystems Dynamics Research · JPGenesis Research Institute · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32024912
PMCPMC7002801
OpenAlexW3004611635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.